On November 9th 2020, German biotech company BioNTech in cooperation with U.S. pharma giant Pfizer were the first to announce a proven COVID-19 vaccine to be ready for mass production by year-end. In 2023, total R&D expenses stood at some 1.78 billion U.S. dollars, an increase from around 1.53 billion dollars in 2022.
Research and development expenses of BioNTech SE from 2017 to 2023
(in million euros)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
BioNTech. (March 20, 2024). Research and development expenses of BioNTech SE from 2017 to 2023 (in million euros) [Graph]. In Statista. Retrieved August 25, 2024, from https://www.statista.com/statistics/1244031/r-and-d-expenses-biontech/
BioNTech. "Research and development expenses of BioNTech SE from 2017 to 2023 (in million euros)." Chart. March 20, 2024. Statista. Accessed August 25, 2024. https://www.statista.com/statistics/1244031/r-and-d-expenses-biontech/
BioNTech. (2024). Research and development expenses of BioNTech SE from 2017 to 2023 (in million euros). Statista. Statista Inc.. Accessed: August 25, 2024. https://www.statista.com/statistics/1244031/r-and-d-expenses-biontech/
BioNTech. "Research and Development Expenses of Biontech Se from 2017 to 2023 (in Million Euros)." Statista, Statista Inc., 20 Mar 2024, https://www.statista.com/statistics/1244031/r-and-d-expenses-biontech/
BioNTech, Research and development expenses of BioNTech SE from 2017 to 2023 (in million euros) Statista, https://www.statista.com/statistics/1244031/r-and-d-expenses-biontech/ (last visited August 25, 2024)
Research and development expenses of BioNTech SE from 2017 to 2023 (in million euros) [Graph], BioNTech, March 20, 2024. [Online]. Available: https://www.statista.com/statistics/1244031/r-and-d-expenses-biontech/